The Chemours Company (NYSE:CC) Receives $17.38 Average Price Target from Brokerages

Key Points

• The Chemours Company has received a consensus recommendation of "Moderate Buy" from nine brokerages, with an average 1-year price target of $17.37.
• CEO Denise Dignam purchased 4,068 shares of Chemours at an average price of $12.06 per share, reflecting her confidence in the company's future.
• Chemours reported earnings of $0.58 EPS, surpassing expectations and indicating a revenue increase of 5.0% year-over-year.

The Chemours Company (NYSE:CC - Get Free Report) has earned an average rating of "Moderate Buy" from the nine analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $17.3750.

A number of equities analysts have recently issued reports on CC shares. Barclays cut their price objective on Chemours from $16.00 to $13.00 and set an "equal weight" rating for the company in a report on Wednesday, May 28th. Wall Street Zen cut Chemours from a "hold" rating to a "sell" rating in a report on Wednesday, May 21st. Zacks Research upgraded Chemours from a "strong sell" rating to a "hold" rating in a report on Wednesday, August 27th. Mizuho boosted their target price on Chemours from $13.00 to $16.00 and gave the company an "outperform" rating in a research note on Tuesday, July 15th. Finally, Royal Bank Of Canada boosted their target price on Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a research note on Thursday, July 3rd.

Insider Buying and Selling at Chemours

In related news, CEO Denise Dignam bought 4,068 shares of the stock in a transaction dated Friday, August 8th. The stock was bought at an average price of $12.06 per share, with a total value of $49,060.08. Following the purchase, the chief executive officer owned 191,546 shares in the company, valued at approximately $2,310,044.76. The trade was a 2.17% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.34% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. UMB Bank n.a. raised its position in shares of Chemours by 73.9% in the 1st quarter. UMB Bank n.a. now owns 2,231 shares of the specialty chemicals company's stock worth $30,000 after acquiring an additional 948 shares in the last quarter. Yousif Capital Management LLC raised its position in shares of Chemours by 1.6% in the 2nd quarter. Yousif Capital Management LLC now owns 62,386 shares of the specialty chemicals company's stock worth $714,000 after acquiring an additional 968 shares in the last quarter. Man Group plc raised its position in shares of Chemours by 0.4% in the 2nd quarter. Man Group plc now owns 271,108 shares of the specialty chemicals company's stock worth $3,104,000 after acquiring an additional 979 shares in the last quarter. CWM LLC raised its position in shares of Chemours by 34.7% in the 2nd quarter. CWM LLC now owns 4,290 shares of the specialty chemicals company's stock worth $49,000 after acquiring an additional 1,104 shares in the last quarter. Finally, Captrust Financial Advisors raised its position in shares of Chemours by 9.7% in the 4th quarter. Captrust Financial Advisors now owns 13,130 shares of the specialty chemicals company's stock worth $222,000 after acquiring an additional 1,165 shares in the last quarter. Institutional investors own 76.26% of the company's stock.

Chemours Stock Performance

Shares of NYSE CC traded down $0.22 during mid-day trading on Friday, hitting $16.46. The company had a trading volume of 996,162 shares, compared to its average volume of 3,527,075. The company has a market capitalization of $2.46 billion, a price-to-earnings ratio of -5.87 and a beta of 1.61. Chemours has a 1 year low of $9.13 and a 1 year high of $22.38. The company has a current ratio of 1.68, a quick ratio of 0.83 and a debt-to-equity ratio of 17.16. The stock's 50-day moving average price is $13.91 and its 200-day moving average price is $12.74.

Chemours (NYSE:CC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The specialty chemicals company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.46 by $0.12. Chemours had a positive return on equity of 35.14% and a negative net margin of 7.19%.The business had revenue of $1.62 billion during the quarter, compared to analysts' expectations of $1.57 billion. During the same period in the previous year, the business earned $0.38 earnings per share. The firm's revenue was up 5.0% on a year-over-year basis. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts forecast that Chemours will post 2.03 earnings per share for the current year.

Chemours Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Stockholders of record on Friday, August 15th will be paid a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, August 15th. Chemours's payout ratio is -12.50%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.